A denileukin diftitox (Ontak) associated retinopathy?
作者信息
Ruddle J B, Harper C A, Hönemann D, Seymour J F, Prince H M
出版信息
Br J Ophthalmol. 2006 Aug;90(8):1070-1. doi: 10.1136/bjo.2006.091165.
Abstract
摘要
相似文献
1
A denileukin diftitox (Ontak) associated retinopathy?白喉毒素融合蛋白（安他克）相关性视网膜病变？
Br J Ophthalmol. 2006 Aug;90(8):1070-1. doi: 10.1136/bjo.2006.091165.
2
Denileukin diftitox and vision loss.地尼白介素-妥西毒素与视力丧失
Leuk Lymphoma. 2007 Apr;48(4):655-6. doi: 10.1080/10428190601186192.
3
Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy.地尼白介素-妥西罗莫司治疗后视力丧失：一例可能的后部缺血性视神经病变病例报告
Leuk Lymphoma. 2007 Apr;48(4):808-11. doi: 10.1080/10428190701268783.
4
Optimizing denileukin diftitox (Ontak) therapy.优化地尼白介素妥西罗汀（昂他克）疗法。
Future Oncol. 2008 Aug;4(4):457-69. doi: 10.2217/14796694.4.4.457.
5
Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia.地尼白介素-匹地毒素（一种白喉毒素融合蛋白）用于既往接受过治疗的慢性淋巴细胞白血病患者的II期临床研究。
Cancer. 2006 May 15;106(10):2158-64. doi: 10.1002/cncr.21851.
6
Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides.蕈样肉芽肿患者接受地尼白介素-毒素融合蛋白治疗后出现甲状腺毒症。
J Clin Endocrinol Metab. 2006 Jun;91(6):2205-8. doi: 10.1210/jc.2005-2839. Epub 2006 Apr 4.
7
Toxic epidermal necrolysis associated with denileukin diftitox (DAB389IL-2) administration in a patient with follicular large cell lymphoma.一名滤泡性大细胞淋巴瘤患者在接受地尼白介素-妥索单抗（DAB389IL-2）治疗后出现中毒性表皮坏死松解症。
Leuk Lymphoma. 2005 Dec;46(12):1807-11. doi: 10.1080/10428190500233764.
8
Denileukin diftitox as novel targeted therapy in non-Hodgkin's lymphoma.地尼白介素-妥西罗汀作为非霍奇金淋巴瘤的新型靶向治疗药物。
Clin J Oncol Nurs. 2004 Apr;8(2):169-74. doi: 10.1188/04.CJON.169-174.
9
Durable complete remission of mycosis fungoides following erythroderma induced by denileukin diftitox.地尼白介素-妥昔单抗诱导红皮病后蕈样肉芽肿的持久完全缓解
J Am Acad Dermatol. 2008 Feb;58(2 Suppl):S31-2. doi: 10.1016/j.jaad.2007.08.033.
10
Denilieukin diftitox vision loss is not posterior ischemic optic neuropathy.地尼白介素妥西罗汀致视力丧失并非后部缺血性视神经病变。
Leuk Lymphoma. 2008 Feb;49(2):370-1; author reply 372. doi: 10.1080/10428190701843254.
引用本文的文献
1
Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor.FOXP3转录因子二聚化及FOXP3/AML1相互作用的阻断抑制调节性T细胞活性：一种肽抑制剂的序列优化
Oncotarget. 2017 May 13;8(42):71709-71724. doi: 10.18632/oncotarget.17845. eCollection 2017 Sep 22.
2
Searching for the Achilles Heel of FOXP3.寻找FOXP3的致命弱点。
Front Oncol. 2013 Dec 3;3:294. doi: 10.3389/fonc.2013.00294.
3
New roads open up for implementing immunotherapy in mesothelioma.间皮瘤免疫治疗的实施开辟了新途径。
Clin Dev Immunol. 2012;2012:927240. doi: 10.1155/2012/927240. Epub 2012 Jun 24.
4
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma.在治疗持续性或复发性皮肤 T 细胞淋巴瘤中的作用。
Cancer Manag Res. 2010 Feb 5;2:53-9. doi: 10.2147/cmar.s5009.
5
Novel therapies in peripheral T-cell lymphomas.外周 T 细胞淋巴瘤的新型治疗方法。
Curr Hematol Malig Rep. 2008 Oct;3(4):213-20. doi: 10.1007/s11899-008-0030-x.
6
Current and emerging treatment strategies for cutaneous T-cell lymphoma.皮肤 T 细胞淋巴瘤的当前和新兴治疗策略。
Drugs. 2010 Feb 12;70(3):273-86. doi: 10.2165/11532190-000000000-00000.
7
Denileukin diftitox for the treatment of cutaneous T-cell lymphoma.地尼白介素-妥西莫单抗用于治疗皮肤T细胞淋巴瘤。
Biologics. 2008 Dec;2(4):717-24. doi: 10.2147/btt.s3084.
8
Novel therapies in peripheral T-cell lymphomas.外周T细胞淋巴瘤的新型疗法。
Curr Oncol Rep. 2008 Sep;10(5):404-11. doi: 10.1007/s11912-008-0062-3.
本文引用的文献
1
Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2.CD4+CD25+调节性T细胞中的信号转导：CD25与白细胞介素-2
Front Biosci. 2006 Jan 1;11:921-7. doi: 10.2741/1848.
2
Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.与抗烯醇化酶抗体相关的副肿瘤性和自身免疫性视网膜病变的临床和电生理特征
Am J Ophthalmol. 2005 May;139(5):780-94. doi: 10.1016/j.ajo.2004.12.104.
3
Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.副肿瘤性和自身免疫性视网膜病变中针对视网膜蛋白的自身抗体。
BMC Ophthalmol. 2004 Jun 4;4:5. doi: 10.1186/1471-2415-4-5.
4
Immune responses to retinal self-antigens in CD25(+)CD4(+) regulatory T-cell-depleted mice.CD25(+)CD4(+)调节性T细胞缺失小鼠对视网膜自身抗原的免疫反应。
Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1879-86. doi: 10.1167/iovs.02-1030.
5
6
Waldenström's macroglobulinemia-associated retinopathy.华氏巨球蛋白血症相关性视网膜病变
Ophthalmology. 2004 Mar;111(3):535-9. doi: 10.1016/j.ophtha.2003.05.036.
7
Lymphoma-associated retinopathy.淋巴瘤相关视网膜病变
Ophthalmology. 2002 Nov;109(11):2149-53. doi: 10.1016/s0161-6420(02)01261-7.
8
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.两种剂量水平的地尼白介素-妥西罗莫司治疗皮肤T细胞淋巴瘤的关键III期试验。
J Clin Oncol. 2001 Jan 15;19(2):376-88. doi: 10.1200/JCO.2001.19.2.376.
Zotero 插件